Santhera Pharmaceuticals Holding AG engages in the development and commercialization of products for the treatment of neuromuscular and pulmonary diseases. Its product pipeline includes Vamorolone and Lonodelestat. The company was founded by Thomas Meier in 1998 and is headquartered in Pratteln, Switzerland.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
78.5
Frequently Asked Questions
What is Market Cap of Santhera Pharmaceuticals Holding AG?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Santhera Pharmaceuticals Holding AG market cap is $238.27M.
What is the 52-week high for Santhera Pharmaceuticals Holding AG?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Santhera Pharmaceuticals Holding AG 52 week high is $19.00 as of September 05, 2025.
What is the 52-week low for Santhera Pharmaceuticals Holding AG?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Santhera Pharmaceuticals Holding AG 52 week low is $9.42 as of September 05, 2025.
What is Santhera Pharmaceuticals Holding AG stock price today?
Santhera Pharmaceuticals Holding AG stock price today is $18.40.
What was Santhera Pharmaceuticals Holding AG stock price yesterday?
Santhera Pharmaceuticals Holding AG stock price yesterday was $14.75.
What is the PE ratio of Santhera Pharmaceuticals Holding AG?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Santhera Pharmaceuticals Holding AG’s P/E ratio is -4.71.
What is the Price-to-Book ratio of Santhera Pharmaceuticals Holding AG?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Santhera Pharmaceuticals Holding AG P/B ratio is 7.7003.
What is the 50-day moving average of Santhera Pharmaceuticals Holding AG?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Santhera Pharmaceuticals Holding AG 50-day moving average is $16.79.
How many employess does Santhera Pharmaceuticals Holding AG has?
Santhera Pharmaceuticals Holding AG has 78.5 employees.
